Changmao Biochemical Engineering Company Limited (0954.HK)
HKD 0.41
(-1.22%)
HKD 0.41
(-1.22%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 494.64 Million CNY | 69.69% |
| 2022 | 291.5 Million CNY | 226.59% |
| 2021 | 89.25 Million CNY | 10987.58% |
| 2020 | 805 Thousand CNY | -96.25% |
| 2019 | 21.44 Million CNY | -45.44% |
| 2018 | 39.31 Million CNY | -27.21% |
| 2017 | 54 Million CNY | 80.02% |
| 2016 | 30 Million CNY | -66.67% |
| 2015 | 90 Million CNY | 0.0% |
| 2014 | 90 Million CNY | -14.29% |
| 2013 | 105 Million CNY | -27.31% |
| 2012 | 144.45 Million CNY | -18.39% |
| 2011 | 177 Million CNY | 65.42% |
| 2010 | 107 Million CNY | -17.69% |
| 2009 | 130 Million CNY | -10.03% |
| 2008 | 144.5 Million CNY | -19.05% |
| 2007 | 178.5 Million CNY | 12.26% |
| 2006 | 159 Million CNY | 89.21% |
| 2005 | 84.03 Million CNY | 3519.04% |
| 2004 | 2.32 Million CNY | 0.0% |
| 2003 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 532.72 Million CNY | 0.34% |
| 2024 Q1 | 532.72 Million CNY | 7.7% |
| 2023 Q3 | 493.68 Million CNY | 18.89% |
| 2023 FY | 494.64 Million CNY | 69.69% |
| 2023 Q4 | 494.64 Million CNY | 0.19% |
| 2023 Q1 | 414.87 Million CNY | 42.32% |
| 2023 Q2 | 415.25 Million CNY | 0.09% |
| 2022 Q1 | 244.5 Million CNY | 173.93% |
| 2022 Q2 | 245.1 Million CNY | 0.25% |
| 2022 Q3 | 290.82 Million CNY | 18.65% |
| 2022 FY | 291.5 Million CNY | 226.59% |
| 2022 Q4 | 291.5 Million CNY | 0.23% |
| 2021 Q2 | 69.3 Million CNY | 0.0% |
| 2021 FY | 89.25 Million CNY | 10987.58% |
| 2021 Q1 | 69.3 Million CNY | 8508.7% |
| 2021 Q3 | 88.67 Million CNY | 27.95% |
| 2021 Q4 | 89.25 Million CNY | 0.66% |
| 2020 Q2 | 1.15 Million CNY | 130.6% |
| 2020 Q3 | 500 Thousand CNY | -56.63% |
| 2020 Q4 | 805 Thousand CNY | 61.0% |
| 2020 Q1 | 500 Thousand CNY | -97.67% |
| 2020 FY | 805 Thousand CNY | -96.25% |
| 2019 Q3 | 20.8 Million CNY | 4061.8% |
| 2019 Q2 | 500 Thousand CNY | 0.0% |
| 2019 Q4 | 21.44 Million CNY | 3.08% |
| 2019 FY | 21.44 Million CNY | -45.44% |
| 2019 Q1 | 500 Thousand CNY | -98.73% |
| 2018 Q4 | 39.31 Million CNY | 0.0% |
| 2018 Q2 | 27.46 Million CNY | 0.0% |
| 2018 FY | 39.31 Million CNY | -27.21% |
| 2018 Q1 | 27.46 Million CNY | -49.14% |
| 2018 Q3 | 39.31 Million CNY | 43.13% |
| 2017 Q3 | 54 Million CNY | 32.87% |
| 2017 Q4 | 54 Million CNY | 0.0% |
| 2017 FY | 54 Million CNY | 80.02% |
| 2017 Q1 | 40.64 Million CNY | 35.49% |
| 2017 Q2 | 40.64 Million CNY | 0.0% |
| 2016 Q3 | 30 Million CNY | -25.0% |
| 2016 FY | 30 Million CNY | -66.67% |
| 2016 Q4 | 30 Million CNY | 0.0% |
| 2016 Q2 | 40 Million CNY | 0.0% |
| 2016 Q1 | 40 Million CNY | -55.56% |
| 2015 Q4 | 90 Million CNY | 0.0% |
| 2015 Q1 | 60 Million CNY | -33.33% |
| 2015 FY | 90 Million CNY | 0.0% |
| 2015 Q2 | 60 Million CNY | 0.0% |
| 2015 Q3 | 90 Million CNY | 50.0% |
| 2014 Q4 | 90 Million CNY | 0.0% |
| 2014 Q3 | 90 Million CNY | -40.28% |
| 2014 Q2 | 150.7 Million CNY | 0.0% |
| 2014 Q1 | 150.7 Million CNY | 43.52% |
| 2014 FY | 90 Million CNY | -14.29% |
| 2013 Q2 | 135 Million CNY | 0.0% |
| 2013 Q3 | 105 Million CNY | -22.22% |
| 2013 Q4 | 105 Million CNY | 0.0% |
| 2013 FY | 105 Million CNY | -27.31% |
| 2013 Q1 | - CNY | -100.0% |
| 2012 FY | 144.45 Million CNY | -18.39% |
| 2012 Q3 | - CNY | -100.0% |
| 2012 Q4 | 144.45 Million CNY | 0.0% |
| 2012 Q2 | 171.58 Million CNY | 0.0% |
| 2011 FY | 177 Million CNY | 65.42% |
| 2011 Q2 | 157 Million CNY | 0.0% |
| 2011 Q4 | 177 Million CNY | 0.0% |
| 2010 Q2 | 140 Million CNY | 0.0% |
| 2010 FY | 107 Million CNY | -17.69% |
| 2010 Q4 | 107 Million CNY | 0.0% |
| 2009 FY | 130 Million CNY | -10.03% |
| 2008 FY | 144.5 Million CNY | -19.05% |
| 2007 FY | 178.5 Million CNY | 12.26% |
| 2006 FY | 159 Million CNY | 89.21% |
| 2005 FY | 84.03 Million CNY | 3519.04% |
| 2004 FY | 2.32 Million CNY | 0.0% |
| 2003 FY | - CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 134.33 Million HKD | -268.218% |
| Lee & Man Chemical Company Limited | 678.91 Million HKD | 27.142% |